3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
5
Active not recruiting
2
Terminated
1
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Meningioma
1
Interventions
pembrolizumab
67
Cyclophosphamide
45
Cisplatin
45
Nivolumab
39
Paclitaxel
35
Carboplatin
31
Radiotherapy
30
Gemcitabine
28
Docetaxel
27
Dexamethasone
23
atezolizumab
22
Bevacizumab
20
Doxorubicin
19
Vincristine
17
Magnetic Resonance Spectroscopy
17
Lenalidomide
17
fludarabine
16
Radiosurgery
16
Fluorouracil
16
Etoposide
16
Blood Specimen Collection
16
Rituximab
15
Radiation
15
Letrozole
15
Irinotecan
15
Ipilimumab
15
palbociclib
14
Leucovorin
14
Cytarabine
14
Surveys and Questionnaires
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Aminolevulinic Acid
×
90 days
×
Clear all
NCT04305470
2026-05-18
MEN-301
NX Development Corp
Phase 3
Completed
108 enrolled
12 charts